$2.05
-1.15-35.85%
In chiusura: Nov 17, 4:00 PM EST
$2.53
0.4823.24%
Post-mercato: 9:12 AM EST

Kyntra Bio (KYNB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 16, 2026 | $-3.42 | $-3.40 | -0.59 % |
| Q2 | Aug 13, 2026 | $-4.68 | $-3.18 | -47.2 % |
| Q4 | Mar 16, 2026 | $-3.61 | $-3.89 | 7.20 % |
| Q3 | Nov 10, 2025 | $-3.25 | $-4.01 | 18.9 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 16, 2026 | $1.76M | $1.77M | -0.27 % |
| Q2 | Aug 13, 2026 | $-1.47M | $2.00M | -173.6 % |
| Q4 | Mar 16, 2026 | $1.30M | $1.64M | -20.8 % |
| Q3 | Nov 10, 2025 | $1.08M | $1.64M | -34.4 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-3.40 | $-3.18 | — | $-3.89 |
| Actual | $-3.42 | $-4.68 | $-3.74 | $-3.61 |
| Surprise | -0.59% | -47.2% | — | +7.20% |
| Revenue | ||||
| Estimate | $1.8M | $2.0M | — | $1.6M |
| Actual | $1.8M | $-1.5M | $3.7M | $1.3M |
| Surprise | -0.27% | -173.6% | — | -20.8% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-3.55 | $-2.87 | $-3.08 | $-3.05 |
| Revenue | ||||
| Consensus | $2.3M | — | — | — |